BioMap
PrivateLast Round
IPO
Mar 16, 2026
Total Funding Raised
$100M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioMap is a biotechnology company that develops AI foundation models for life sciences to accelerate drug discovery and biological research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioMap Comparables
Compare BioMap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insilico Medicine | 85% | |
| Generate Biomedicines | 85% | |
| Chai Discovery | 84% |
BioMap Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Mar 16, 2026 | ||||
| VC Round | Jun 24, 2024 | ||||
| Series A | Jul 30, 2021 |
BioMap Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hong Kong Investment Corporation | VC Round |
| Lanchi Ventures | Series A |
| Legend Capital | Series A |
| BlueRun Ventures | Series A |
| Xiang He Capital | Series A |
| GGV Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 31% MoM, reaching 10.4K.
- Mar 16, 2026
Completed an IPO round.
BioMap Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioMap's valuation, stock price, and market status.
Is BioMap a public or private company?
BioMap is a private company.
What is the current stock price of BioMap?
BioMap is a private company with no public stock price. No recent secondary market data is available.
How much is BioMap worth (valuation)?
Valuation information for BioMap is not publicly available.
Can I buy BioMap stock?
BioMap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioMap's last funding round?
BioMap's most recent funding round was IPO on March 16, 2026.
Who are the main investors in BioMap?
Key investors in BioMap include Hong Kong Investment Corporation, GGV Capital.
Will BioMap IPO soon?
No public IPO plans have been announced for BioMap.
How can I track BioMap secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioMap's secondary market activity and sign up for updates.